Millipore insiders, Madaus eye big payouts
Boston Business Journal - by Craig M. Douglas
Monday, March 1, 2010, 2:12pm EST | Modified: Monday, March 1, 2010, 3:16pm
Millipore insiders, Madaus eye big payouts
Boston Business Journal - by Craig M. Douglas
Monday, March 1, 2010, 2:12pm EST | Modified: Monday, March 1, 2010, 3:16pm
Just read that on Feb 11th, the board of General Electric (NYSE:GE) is convening to review the company’s decision to launch a formal friendly bid to take a 100 percent stake in the Life Technologies Corporation (NASDAQ: LIFE) in a deal worth $10.4 billion. Has anyone heard about this?
Spectrum buying into cancer drug which is potential blockbuster. Not cheap, but probably worth it...
Spectrum Pharmaceuticals Licenses Belinostat, a Novel Anticancer Drug in a Pivotal Registrational Trial
•Belinostat, a HDAC Inhibitor, is Currently in a Multicenter, Registrational Trial Under a Special Protocol Assessment for Peripheral T-Cell Lymphoma (PTCL)
How will this stack up to Complete Gen and Pac Bio?
eXample Consulting Group (India’s #1 Lean Six Sigma Consulting, advisory, training and certification firm) is conducting an immensely practical 3 day SIX SIGMA GREEN BELT CERTIFICATION weekend public workshop in GURGAON (DELHI / NCR), India on 12, 13 and 14th FEBRUARY 2010 (Fri to Sun) at Hotel Windsor Castle, Jacranda Marg, Gurgaon, India.
Wyeth shareholders are scheduled to vote on July 20. Does any know of how long after shareholders vote that mergers usually are completed???
I have been told that Dr. B is getting tired of writing checks to keep Adaltis alive. The China business has been a joke since they partnered up on the rapid diagnostic side and abandoned their very profitable Serozyme business. Does this mean Trinity will finally swoop in and get them ?